Declaration of results for the Quarter and half year ending 30th September, 2025

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.4%Reaction day

₹59.10

prior close

₹59.20

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.4%-0.1% vs market

Pharmaceuticals peers, median of 155sector-0.1%-0.3% vs sector

On the reaction day the stock moved 0.1 pts less than Nifty Microcap 250 and 0.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.4

10m

+0.2

15m

+1.2

30m

+1.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.4-0.4-0.1-0.1-0.3

Next day

-0.6-0.6+0.0-0.8+0.2

-3.1+0.3-3.4+0.4-3.5

-5.9+0.2-6.1+0.0-5.9

-3.6+0.1-3.7+0.4-3.9

-3.5+0.7-4.2+0.3-3.8

-3.9-0.3-3.6-0.7-3.2

15d

-7.3-2.0-5.3-1.4-5.9

-19.4-5.7-13.7-3.6-15.8

-13.7-7.8-5.9-6.2-7.5

-10.3-4.6-5.7-6.7-3.6

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 155Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Syschem India reported a strong Q2 FY26 with revenue from operations of Rs 117.92 crore, more than double the Rs 54.21 crore posted in Q2 FY25. Half-year (H1 FY26) revenue stood at Rs 244.68 crore, up about 56% from Rs 156.36 crore in H1 FY25. The company swung to a profit of Rs 1.90 crore in Q2 (from a Rs 0.64 crore loss) and Rs 3.57 crore for the half year (from a Rs 0.50 crore loss). Operating cash flow turned positive at Rs 13.24 crore for the half year, compared to a negative figure at the end of FY25. The balance sheet shows no long-term borrowings, total equity of Rs 94.86 crore, and cash of Rs 4.41 crore. The statutory auditor issued an unqualified limited review report.

Likely market impact

Sharp revenue growth, a clear swing back to profit, debt-free status, and positive operating cash flow are positive signals for shareholders. The numbers suggest improving business momentum, though margins remain thin and the results are unaudited.